Press Releases
Lupus Research Alliance Prompted Stelara® Study for Lupus

Lupus Research Alliance welcomes compelling new data, presented at the American College of Rheumatology (ACR) annual meeting that demonstrated significant benefit for lupus patients treated with Stelara® (ustekinumab), a prescription medicine from the Janssen Pharmaceutical Companies. Stelara® is not approved for the treatment of lupus, but is approved by the FDA for certain autoimmune diseases. Through its drug repurposing program, the Lupus Research Alliance first identified Stelara® as a potential treatment for lupus and encouraged Janssen to pursue testing for this use. READ MORE

Lupus Research Alliance LuCIN Clinical Trials Network Launches Inaugural Studies

NEW YORK, NY. October 31, 2017 — The Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN) aimed at discovering new treatments for the millions of people around the globe living with lupus. Recognizing the limited treatments for lupus, LuCIN was organized, managed and is […] READ MORE

Lupus Research Alliance Welcomes Self-Injectable Form of Belimumab

The Lupus Research Alliance congratulates GlaxoSmithKline (GSK) on the approval of belimumab (Benlysta®) by the U.S. Food and Drug Administration as a self-injectable (subcutaneous) formulation for people with systemic lupus erythematosus being treated with standard therapy. Belimumab is currently approved as a one-hour intravenous infusion given once every four weeks by a healthcare professional in […] READ MORE

Multi-ethnic Study Identifies New Genetic Markers for Lupus

Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus. The study is published in the July 17 issue of the journal Nature Communications and was led by researchers at Wake Forest Baptist Medical Center, Oklahoma Medical Research Foundation, King’s College of London and Genentech Inc. Autoimmune diseases […] READ MORE

President Signs Bill that Advances Lupus Research and Care

May 5, 2017. NEW YORK, NY. A bipartisan spending bill for Fiscal 2017 that includes key provisions the Lupus Research Alliance and lupus advocates across the country have fought for was signed into law today. The bill establishes for the first time an annual $5 million lupus medical research program at the Department of Defense […] READ MORE

2017 Lupus Handbag Luncheon Supports Science With Style

NEW YORK, NY – April 4, 2017. Nearly 300 prominent women and men from New York’s fashion, society, entertainment, publishing, philanthropic and lupus communities came together today to raise funds for lupus research. The 8th annual Lupus Handbag Luncheon & Silent Auction was the first hosted by the Lupus Research Alliance, formed by the recent merger […] READ MORE

Lupus Research Alliance Inaugural Gala Honors Founding Board & Pfizer Inc

NEW YORK, NY – The newly merged Lupus Research Alliance celebrated its debut at the Inaugural Gala, uniting the three world leaders in lupus research as the driving force for better treatments and a cure. In just one night, the country’s largest lupus fundraising event raised over $2.5 million – with every dollar going directly to support lupus […] READ MORE

Learn and connect with our community!